FI970430A0 - Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina - Google Patents
Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreinaInfo
- Publication number
- FI970430A0 FI970430A0 FI970430A FI970430A FI970430A0 FI 970430 A0 FI970430 A0 FI 970430A0 FI 970430 A FI970430 A FI 970430A FI 970430 A FI970430 A FI 970430A FI 970430 A0 FI970430 A0 FI 970430A0
- Authority
- FI
- Finland
- Prior art keywords
- inhibitors
- aspartic acid
- converting enzyme
- acid analogs
- interleukin converting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/284,861 US5565430A (en) | 1994-08-02 | 1994-08-02 | Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors |
PCT/US1995/009668 WO1996003982A1 (en) | 1994-08-02 | 1995-07-31 | Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970430A0 true FI970430A0 (fi) | 1997-01-31 |
FI970430A FI970430A (fi) | 1997-04-01 |
Family
ID=23091800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970430A FI970430A (fi) | 1994-08-02 | 1997-01-31 | Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina |
Country Status (8)
Country | Link |
---|---|
US (1) | US5565430A (fi) |
EP (1) | EP0767661A4 (fi) |
JP (1) | JPH10504816A (fi) |
AU (1) | AU684993B2 (fi) |
CA (1) | CA2196183A1 (fi) |
FI (1) | FI970430A (fi) |
NO (1) | NO970410L (fi) |
WO (1) | WO1996003982A1 (fi) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5714484A (en) * | 1993-12-08 | 1998-02-03 | Prototek, Inc. | α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US6420522B1 (en) * | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
WO1996030395A2 (en) * | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
US6416753B1 (en) | 1996-03-15 | 2002-07-09 | The General Hospital Corporation | Method for modulating apoptosis |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US6184210B1 (en) | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
WO1999018781A1 (en) * | 1997-10-10 | 1999-04-22 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
EP1062210B1 (en) | 1998-03-09 | 2005-06-01 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
WO1999047154A1 (en) * | 1998-03-16 | 1999-09-23 | Cytovia, Inc. | Dipeptide caspase inhibitors and the use thereof |
RU2274642C2 (ru) | 1998-03-19 | 2006-04-20 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы каспаз |
DE19818732A1 (de) * | 1998-04-27 | 1999-10-28 | Bayer Ag | Arylphenylsubstituierte cyclische Ketoenole |
DE60030097T2 (de) | 1999-03-16 | 2007-03-08 | Cytovia, Inc., San Diego | Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung |
EP1177168B1 (en) | 1999-04-09 | 2007-05-30 | Cytovia, Inc. | Caspase inhibitors and the use thereof |
KR20020033777A (ko) * | 1999-08-27 | 2002-05-07 | 추후보정 | 치환된 α-히드록시 산 카스파제 억제제 및 이의 용도 |
US6566338B1 (en) | 1999-10-12 | 2003-05-20 | Cytovia, Inc. | Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
AU2003211052A1 (en) | 2002-02-11 | 2003-09-04 | Vertex Pharmaceuticals Incorporated | Phospholipids as caspase inhibitor prodrugs |
EP1499593A4 (en) | 2002-04-30 | 2006-02-01 | Yungjin Pharmacautical Co Ltd | CHINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
TW200500343A (en) | 2002-12-20 | 2005-01-01 | Vertex Pharma | Caspase inhibitors and uses thereof |
PE20050159A1 (es) | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
JP4848367B2 (ja) * | 2004-05-15 | 2011-12-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | Iceインヒビターを使用した発作の処置 |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
CN1980658A (zh) * | 2004-05-27 | 2007-06-13 | 沃泰克斯药物股份有限公司 | 治疗自身炎性疾病的ice抑制剂 |
EP2635906A4 (en) | 2010-11-05 | 2014-04-02 | Univ Brandeis | ICE INHIBITING COMPOUNDS AND USES THEREOF |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69226820T2 (de) * | 1991-06-21 | 1999-05-12 | Merck & Co Inc | Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen |
GB9123326D0 (en) * | 1991-11-04 | 1991-12-18 | Sandoz Ltd | Improvements in or relating to organic compounds |
EP0627926B1 (en) * | 1992-02-21 | 1998-08-05 | Merck & Co., Inc. (a New Jersey corp.) | PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
-
1994
- 1994-08-02 US US08/284,861 patent/US5565430A/en not_active Expired - Lifetime
-
1995
- 1995-07-31 CA CA002196183A patent/CA2196183A1/en not_active Abandoned
- 1995-07-31 JP JP8506684A patent/JPH10504816A/ja active Pending
- 1995-07-31 WO PCT/US1995/009668 patent/WO1996003982A1/en not_active Application Discontinuation
- 1995-07-31 EP EP95928696A patent/EP0767661A4/en not_active Withdrawn
- 1995-07-31 AU AU32354/95A patent/AU684993B2/en not_active Ceased
-
1997
- 1997-01-30 NO NO970410A patent/NO970410L/no not_active Application Discontinuation
- 1997-01-31 FI FI970430A patent/FI970430A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
AU684993B2 (en) | 1998-01-08 |
EP0767661A4 (en) | 1998-06-10 |
FI970430A (fi) | 1997-04-01 |
EP0767661A1 (en) | 1997-04-16 |
US5565430A (en) | 1996-10-15 |
CA2196183A1 (en) | 1996-02-15 |
AU3235495A (en) | 1996-03-04 |
NO970410D0 (no) | 1997-01-30 |
JPH10504816A (ja) | 1998-05-12 |
MX9700828A (es) | 1997-10-31 |
WO1996003982A1 (en) | 1996-02-15 |
NO970410L (no) | 1997-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970430A0 (fi) | Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina | |
NO991677L (no) | Aspartatester-inhibitorer for interleukin-1-<beta>-omdannelsesenzym | |
PT817613E (pt) | Utilizacao de composicoes compreendendo enzimas estabilizadas | |
DK1038008T3 (da) | Fremgangsmåde til fremstilling af EGIII-lignende enzymer | |
PL318220A1 (en) | Inhibitors of interleukin-1 converting enzyme | |
NO965365L (no) | Hemmere av interleukin-1<beta> omdannende enzym | |
PT0900782E (pt) | Ester do acido 2-cianacrilico | |
EE03525B1 (et) | Kompositsioonid nuumrakkude vahendatud põletikuliste seisundite raviks | |
IT1289155B1 (it) | Composizioni granulari di acido e-ftalimmido perossiesanoico | |
ID17287A (id) | Penyempurnaan propagasi tanaman | |
DK349586A (da) | Enzyminhibitor | |
DK152764C (da) | Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt | |
ATE303153T1 (de) | Ibandroinsäure zur förderung der osseointegration der endoprothesen | |
IT8520090A0 (it) | Procedimento di purificazione di un enzima. | |
DE3485210D1 (de) | Immobilisierte enzymzusammensetzungen. | |
NO986145D0 (no) | Ikke-vandige renseblandinger inneholdende enzymer | |
DK159329C (da) | Fremgangsmaade til kontinuerlig enzymatisk omdannelse af alfa-hydroxycarboxylsyrer til de tilsvarende optisk aktive alfa-aminocarboxylsyrer | |
ID20291A (id) | Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa | |
DK167185A (da) | Fremgangsmaade til fremstilling af stoebejern med vermicular-grafit | |
DE69724641D1 (de) | Reinigung von fermentierter clavulansäure | |
DK210085D0 (da) | Fremgangsmaade til fremstilling af bakterielle enzymer | |
IT1283642B1 (it) | Procedimento per la preparazione di acido poliaspartico | |
DK602288D0 (da) | Mellemprodukter til fremstilling af halogenerede proteaseinhibitorer | |
IT8422177A0 (it) | Procedimento per la preparazione di esteri. | |
FI972620A (fi) | Uusia prosesseja, joilla voidaan valmistaa enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteita ja näiden välituotteita |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: VERTEX PHARMACEUTICALS INCORPORATED |